Market closedNon-fractional
Biodesix/BDSX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Biodesix
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Ticker
BDSX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Providers and Services
Headquarters
Louisville, United States
Employees
217
Website
www.biodesix.com
Biodesix Metrics
BasicAdvanced
$241M
Market cap
-
P/E ratio
-$0.54
EPS
1.14
Beta
-
Dividend rate
Price and volume
Market cap
$241M
Beta
1.14
Financial strength
Current ratio
0.912
Quick ratio
0.685
Long term debt to equity
-1,112.141
Total debt to equity
-1,124.228
Interest coverage (TTM)
-3.71%
Management effectiveness
Return on assets (TTM)
-26.71%
Return on equity (TTM)
9,886.13%
Valuation
Price to revenue (TTM)
2.632
Price to book
-29.34
Price to tangible book (TTM)
-5.78
Price to free cash flow (TTM)
-3.13
Growth
Revenue change (TTM)
34.70%
Earnings per share change (TTM)
-57.53%
3-year revenue growth (CAGR)
-7.51%
3-year earnings per share growth (CAGR)
-39.98%
What the Analysts think about Biodesix
Analyst Ratings
Majority rating from 4 analysts.
Biodesix Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$15M
1.37%
Net income
-$14M
49.45%
Profit margin
-91.89%
47.45%
Biodesix Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.17
-$0.14
-$0.10
-$0.14
-
Expected
-$0.21
-$0.15
-$0.11
-$0.14
-$0.09
Surprise
-17.74%
-6.67%
-9.09%
-2.33%
-
Biodesix News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Biodesix stock?
Biodesix (BDSX) has a market cap of $241M as of July 27, 2024.
What is the P/E ratio for Biodesix stock?
The price to earnings (P/E) ratio for Biodesix (BDSX) stock is 0 as of July 27, 2024.
Does Biodesix stock pay dividends?
No, Biodesix (BDSX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Biodesix dividend payment date?
Biodesix (BDSX) stock does not pay dividends to its shareholders.
What is the beta indicator for Biodesix?
Biodesix (BDSX) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Biodesix stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.